C72.3

Clinical Causes: Genetic mutations that lead to abnormal cell growth in the optic nerve History of radiation exposure to the head or eyes Pre-existing conditions such as neurofibromatosis Unidentified environmental factors that may contribute to malignant transformations Potential familial predisposition, though specific genetic links are not well established

Key Symptoms: Gradual or sudden loss of vision in one or both eyes Blurred or dim vision Visual field defects such as blind spots or peripheral vision loss Eye pain or discomfort, less common Presence of a mass or swelling in the eye or surrounding areas Changes in color perception Possible headache or signs related to increased intracranial pressure

Diagnosis Path: - Detailed eye examinations, including visual acuity tests and fundoscopic evaluations - Magnetic resonance imaging (MRI) of the brain and orbits to visualize the optic nerve and surrounding structures - Computed tomography (CT) scans if necessary - Biopsy procedures to confirm the presence of malignant cells, although biopsies of the optic nerve are challenging due to its delicate location - Additional neurological assessments if symptoms suggest intracranial involvement

Treatment Protocols: - Surgical removal of the tumor when feasible, though this can be complex due to the nerve's sensitive location - Radiation therapy aimed at shrinking or controlling tumor growth - Chemotherapy, used in cases where the tumor has spread or is difficult to treat with surgery and radiation alone - Targeted therapies or immunotherapy may be considered, depending on the tumor type and advancements in cancer treatment - Supportive and rehabilitative services to assist with vision loss and related challenges